NSW is committing $96 million to establish a facility to develop and manufacture the emerging medical technology of mRNA and RNA drugs used to develop vaccines like those created for COVID-19 by Pfizer and Moderna. Premier Dominic Perrottet said the facility—at a site yet to be determined—would position the state as a world leader in biotechnology, noting it would be a game-changer in the field of medical research. The investment in RNA and biotechnology reflects the government’s new focus on research and development and a move to attract and train the best and brightest minds in developing emerging technologies. “The NSW government doesn’t just want to be nation-leading, but world-leading when it comes to industry, ideas and innovation,” he said on Thursday. “If there is anything that this pandemic has taught us it is that governments need to be ahead of the curve,” he said. The facility would be “the …